PMA device
Trifecta Valve with Glide Technology
Abbott Medical · Heart-Valve, Non-Allograft Tissue (LWR, Class III) · First FDA decision Dec 22, 2011, newest Apr 24, 2016Aortic stenosisMitral regurgitationTricuspid regurgitation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
11
Naming "Trifecta"
MAUDE reports
2,732
Brand "Trifecta", since 2015
PubMed studies
950
Mentioning "Trifecta"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Trifecta Valve with Glide Technology
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- TRIFECTA VALVE WITH GLIDE TECHNOLOGYPMA supplement
P100029-S021 · Decided Apr 24, 2016 · 205 days after receipt · Normal 180 Day Track
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
- TRIFECTA HEART VALVEPMA supplement
P100029-S003 · Decided Dec 22, 2011 · 216 days after receipt · Normal 180 Day Track No User Fee
Device type: heart-valve, non-allograft tissue (LWR) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Trifecta", any status and sponsor, newest update first.
- Trifecta Research StudyActive, not recruiting
Axial Therapeutic ResearchNot on our public-company list
NCT07717866 · 52 participants · Start Aug 1, 2022 · Primary completion Feb 1, 2026
Device: Magnetic e-Resonance Therapy (MeRT) · For: PTSD - Post Traumatic Stress Disorder; Cognitive Dysfunction; Brain Injury and 2 more
Sites: Northridge, California
Abbott Medical DevicesPublic (ABT)
NCT01593917 · 329 participants · Start Jul 2, 2012 · Primary completion Sep 26, 2019
Device: Trifecta™ Valve · For: Aortic Valve Insufficiency; Aortic Valve Regurgitation; Aortic Valve Stenosis and 1 more
Sites: Los Angeles, California; Minneapolis, Minnesota; Rochester, Minnesota · 11 sites in all
Abbott Medical DevicesPublic (ABT)
NCT03016169 · 358 participants · Start Mar 9, 2017 · Primary completion Apr 25, 2023
Device: Trifecta GT (Glide Technology) Valve · For: Aortic Valve Disease; Aortic Valve Disorder
Sites: Rochester, Minnesota; Asheville, North Carolina; Wynnewood, Pennsylvania · 27 sites in all
8 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Trifecta", and for the whole product code for context.
This brand
2,732 reports: 131 malfunction, 2,363 injury, 237 death
Whole product code LWR
17,256 reports: 871 malfunction, 15,439 injury, 934 death
Newest reports for this brand
- Trifecta¿ GT ValveInjury
2135147-2026-07237 · Received Oct 28, 2026 · Event dated May 27, 2026
Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Arrhythmia
- Trifecta¿Injury
2135147-2026-07238 · Received Oct 28, 2026 · Event dated Sep 24, 2019
Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
- Trifecta¿ GT ValveInjury
2135147-2026-07239 · Received Oct 28, 2026 · Event dated Aug 4, 2026
Device type: Heart-Valve, Non-Allograft Tissue (LWR)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: Insufficient Information
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Trifecta"[tiab]. The summary above synthesizes these.
- Trifecta Degeneration?
Baciewicz FA · Ann Thorac Surg · 2021Letter, Comment
- Editorial: unravelling the trifecta: obesity, cancer, and DNA damage.
Kalea AZ, Klimis-Zacas D · Curr Opin Clin Nutr Metab Care · 2024Editorial, Introductory Journal Article
- Developers-Doctor-patients: the artificial intelligence's trifecta.
Nicoletti R, Nicoletti G, Giannini V, et al. · Prostate Cancer Prostatic Dis · 2024Editorial
- "Trifecta" in partial nephrectomy.
Hung AJ, Cai J, Simmons MN, et al. · J Urol · 2013
- Commentary: Wagering on Trifecta.
Errico K, Hui DS · J Thorac Cardiovasc Surg · 2023Editorial, Comment
- Trifecta and Carpentier Edwards aortic bioprostheses: Comparison of six years follow-up outcomes.
Pfister R, Frey V, Kirsch M, et al. · Asian Cardiovasc Thorac Ann · 2023
- Trifecta for the practice environment.
Nurs Manage · 2025
- Trifecta versus Perimount Magna Ease aortic valves: Failure mechanisms.
Suzuki R, Ito T, Suzuki M, et al. · Asian Cardiovasc Thorac Ann · 2022
- Achieving trifecta outcomes in robotic-assisted partial nephrectomy within a fellowship training centre.
Kinnear N, Kucheria A, Warner R, et al. · J Robot Surg · 2024
- A cognitive neuroscience trifecta.
Harvey PD · Am J Psychiatry · 2014Editorial, Comment
- Intraoperative Trifecta Valve Malfunction.
Kataoka H, Tanaka H, Toshida T, et al. · Ann Thorac Surg · 2021Case Reports
- An Agrigenomics Trifecta: Greenhouse Gas Drawdown, Food Security, and New Drugs.
DeLisi C · Cold Spring Harb Perspect Biol · 2024Review, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code LWR.
- Edwards Pericardial Aortic Bioprosthesis and INSPIRIS RESILIA Aortic ValveEdwards Lifesciences, LLC · PMA 2022
- St. Jude Medical Biocor and Biocor Supra ValvesAbbott Medical · PMA 2012
- INSPIRIS RESILIA Aortic ValveEdwards Lifesciences, LLC · PMA 2026
- Mitroflow Aortic Pericardial Heart ValveCorcym Canada Corp · PMA 2019
- TRIFORMIS RESILIA Tricuspid ValveEdwards Lifesciences, LLC · PMA 2026
- Perceval Sutureless Heart Valve, Perceval Plus Sutureless Heart ValveCorcym S.r.l. · PMA 2025
- Sjm Biocor Valve / Sjm Biocor Supra ValveAbbott Medical · PMA 2016
- Ats 3F Aortic Bioprosthesis Model 1000Medtronic, Inc. · PMA 2019
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.